tirzepatide nhs uk What is Mounjaro? Everything to know about approved weight loss jab Mounjaro approved for use in

Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness

The Bottom Line: Why Am I Not Losing Weight on Tirzepatide If youre asking, Why am I not losing weight on tirzepatide?, the answer is rarely simple, but its also rarely hopeless

FLOW) improve atherogenic lipoprotein measures in clinical research (tirzepatide: apoB , apoC-III , triglyceride-rich particles

That is the difference between a therapeutic dose and a potentially problematic one

2021;143:e984e1010